Key result
Experimental autoimmune myocarditis in rats increased the incidence of sustained ventricular tachycardia (80% vs 0%, P=0.01) via increased phosphorylation of Ca2+ handling proteins, which was reversed by steroid treatment and CaMKII inhibition.
Why the study?
Does experimental autoimmune myocarditis increase arrhythmia incidence via phosphorylation of Ca2+ handling proteins in a rat model?
Does experimental autoimmune myocarditis increase arrhythmia incidence via phosphorylation of Ca2+ handling proteins in a rat model?
Absolute Event Rate: 80% vs 0%
p-value: p=0.01
Experimental autoimmune myocarditis increases the incidence of ventricular arrhythmias through inflammation-induced hyperphosphorylation of Ca2+ handling proteins, which can be attenuated by steroids or CaMKII inhibition.
Animal data identify CaMKII inhibition as potential antiarrhythmic strategy in myocarditis; leaves open translation to human disease.
BACKGROUND: Because fatal arrhythmia is an important cause of death in patients with myocarditis, we investigated the proarrhythmic mechanisms of experimental autoimmune myocarditis. METHODS AND RESULTS: Myocarditis was induced by injection of 2 mg porcine cardiac myosin into the footpads of adult Lewis rats on days 1 and 8 (Myo, n=15) and the results compared with Control rats (Control, n=15). In an additional 15 rats, 6 mg/kg prednisolone was injected into the gluteus muscle before the injection of porcine cardiac myosin on days 1 and 8 (MyoS, n=15). Hearts with myocarditis had longer action potential duration (APD), slower conduction velocity (CV; P<0.01 vs. Control), higher CV heterogeneity, greater fibrosis, higher levels of immunoblotting of high-mobility group protein B1, interleukin 6 and tumor necrosis factor-α proteins. Steroid treatment partially reversed the translations for myocarditis, CV heterogeneity, reduced APD at 90% recovery to baseline, increased CV (P<0.01), and reversed fibrosis (P<0.05). Programmed stimulation triggered sustained ventricular tachycardia in Myo rats (n=4/5), but not in controls (n=0/5) or Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) inhibitor (KN93) treated Myo rats (n=0/5, P=0.01). CaMKII autophosphorylation at Thr287 (201%), and RyR2 phosphorylation at Ser2808 (protein kinase A/CaMKII site, 126%) and Ser2814 (CaMKII site, 21%) were increased in rats with myocarditis and reversed by steroid. CONCLUSIONS: The myocarditis group had an increased incidence of arrhythmia caused by increased phosphorylation of Ca(2+)handling proteins. These changes were partially reversed by an antiinflammatory treatment and CaMKII inhibition.
No takes yet. Share an insight, caveat, or question.
Park et al. (2014) studied Experimental autoimmune myocarditis (n=45). Experimental autoimmune myocarditis vs. Control (complete Freund's adjuvant) was evaluated on Sustained ventricular tachycardia triggered by programmed stimulation (p=0.01). Experimental autoimmune myocarditis in rats increased the incidence of sustained ventricular tachycardia (80% vs 0%, P=0.01) via increased phosphorylation of Ca2+ handling proteins, which was reversed by steroid treatment and CaMKII inhibition.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: